Skip to main content
. 2016 Sep 14;7(45):72819–72832. doi: 10.18632/oncotarget.12022

Table 5. Prognostic impact of CD68 and CD20 according to stroma density.

Marker expression (high vs low) OS p-value PFS p-value LPFS p-value DMFS p-value
Total CD68
 Dense stroma 0.725 0.954 0.509 0.804
 Moderate stroma 0.307 0.102 0.096 0.940
 Loose Stroma 0.399 0.256 0.988 0.283
Total CD20
 Dense stroma 0.736 0.701 0.753 0.804
 Moderate stroma 0.373 0.955 0.975 0.940
 Loose Stroma 0.366 0.269 0.199 0.333
Stromal compartment CD68
 Dense stroma 0.370 0.884 0.439 0.964
 Moderate stroma 0.454 0.185 0.305 0.243
 Loose Stroma 0.331 0.017 0.182 0.023
Stromal compartment CD20
 Dense stroma 0.473 0.196 0.210 0.235
 Moderate stroma 0.647 0.827 0.957 0.834
 Loose Stroma 0.214 0.514 0.333 0.536
Tumor compartment CD68
 Dense stroma 0.113 0.126 0.133 0.196
 Moderate stroma 0.292 0.063 0.105 0.069
 Loose Stroma 0.748 0.775 0.496 0.796
Tumor compartment CD20
 Dense stroma N/A N/A N/A N/A
 Moderate stroma 0.678 0.981 0.609 0.823
 Loose Stroma N/A N/A N/A N/A
Peripheral compartment CD68
 Dense stroma 0.432 0.398 0.460 0.559
 Moderate stroma 0.065 0.013 0.044 0.048
 Loose Stroma 0.153 0.985 0.372 0.989
Peripheral compartment CD20
 Dense stroma 0.483 0.544 0.089 0.097
 Moderate stroma 0.785 0.189 0.375 0.272
 Loose Stroma 0.393 0.761 0.693 0.601

Abbreviations: OS, overall survival; PFS, progression-free survival; LFFS, local failure-free survival; DMFS, distant metastases-free survival; significant values have been marked with bold.